| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ABCC1 NALCN P2RX7 SCN1A SCN3A SLC49A4 SCN8A SCN9A TMEM63B KCNQ2 ATP11C ATP8B1 SLC25A26 ATP1B2 LMBRD1 ABCA10 RHCE RHD | 4.91e-09 | 1289 | 55 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 8.28e-09 | 26 | 55 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 2.51e-08 | 12 | 55 | 4 | GO:0016175 | |
| GeneOntologyMolecularFunction | sodium ion binding | 5.05e-08 | 14 | 55 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activity | 7.89e-08 | 4 | 55 | 3 | GO:0106292 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 2.41e-07 | 20 | 55 | 4 | GO:0050664 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.10e-07 | 52 | 55 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 NALCN P2RX7 SCN1A SCN3A SLC49A4 SCN8A SCN9A TMEM63B KCNQ2 SLC25A26 ATP1B2 ABCA10 RHCE RHD | 4.35e-07 | 1180 | 55 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.36e-07 | 26 | 55 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | channel activity | 1.46e-06 | 525 | 55 | 10 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.49e-06 | 526 | 55 | 10 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.21e-06 | 343 | 55 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 NALCN SCN1A SCN3A SCN8A SCN9A TMEM63B KCNQ2 ATP1B2 RHCE RHD | 5.70e-06 | 758 | 55 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.09e-06 | 627 | 55 | 10 | GO:0022890 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.40e-06 | 171 | 55 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.46e-05 | 459 | 55 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 7.41e-05 | 5 | 55 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.62e-05 | 664 | 55 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.36e-04 | 95 | 55 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 1.55e-04 | 7 | 55 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.65e-04 | 9 | 55 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | 2-acylglycerol-3-phosphate O-acyltransferase activity | 2.65e-04 | 9 | 55 | 2 | GO:0047144 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.74e-04 | 465 | 55 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.89e-04 | 793 | 55 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 4.83e-04 | 12 | 55 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 4.83e-04 | 12 | 55 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 6.64e-04 | 14 | 55 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | floppase activity | 8.72e-04 | 16 | 55 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | flippase activity | 9.87e-04 | 17 | 55 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPR61 OR52A4P P2RX7 MRGPRE MFSD6 TMEM63B ADGRF4 OPN1SW VN1R1 NPFFR1 ADCYAP1R1 | 9.98e-04 | 1353 | 55 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.08e-03 | 164 | 55 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | 1-acylglycerol-3-phosphate O-acyltransferase activity | 1.51e-03 | 21 | 55 | 2 | GO:0003841 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid acyltransferase activity | 1.98e-03 | 24 | 55 | 2 | GO:0042171 | |
| GeneOntologyMolecularFunction | lysophospholipid acyltransferase activity | 1.98e-03 | 24 | 55 | 2 | GO:0071617 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.08e-03 | 196 | 55 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.69e-03 | 28 | 55 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 2.75e-03 | 884 | 55 | 8 | GO:0004930 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.38e-03 | 109 | 55 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 3.50e-03 | 32 | 55 | 2 | GO:0016411 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 3.72e-03 | 33 | 55 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 8.06e-03 | 49 | 55 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | molecular sensor activity | 8.38e-03 | 50 | 55 | 2 | GO:0140299 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 8.71e-03 | 51 | 55 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | heme binding | 8.80e-03 | 154 | 55 | 3 | GO:0020037 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.31e-08 | 63 | 53 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 2.91e-07 | 55 | 53 | 5 | GO:0045332 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.18e-07 | 112 | 53 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | lipid translocation | 4.53e-07 | 60 | 53 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.76e-07 | 275 | 53 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYBB ABCC1 NALCN P2RX7 SCN1A SCN3A SCN8A SCN9A TMEM63B KCNQ2 ATP11C ATP8B1 ATP1B2 ADCYAP1R1 | 5.55e-07 | 1115 | 53 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | membrane depolarization | 6.59e-07 | 121 | 53 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 6.79e-07 | 65 | 53 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.97e-07 | 208 | 53 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYBB ABCC1 NALCN P2RX7 SCN1A SCN3A SCN8A SCN9A TMEM63B KCNQ2 ATP11C ATP8B1 SLC25A26 ATP1B2 ADCYAP1R1 | 1.18e-06 | 1374 | 53 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.15e-06 | 36 | 53 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 7.69e-06 | 106 | 53 | 5 | GO:0015914 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 8.20e-06 | 50 | 53 | 4 | GO:0042554 | |
| GeneOntologyBiologicalProcess | action potential | 1.25e-05 | 201 | 53 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | NALCN P2RX7 SCN1A SCN3A SCN8A SCN9A KCNQ2 ATP1B2 ADCYAP1R1 RHCE RHD | 1.82e-05 | 922 | 53 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.94e-05 | 62 | 53 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 3.23e-05 | 238 | 53 | 6 | GO:0050954 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | NALCN P2RX7 SCN1A SCN3A SCN8A SCN9A KCNQ2 ATP1B2 ADCYAP1R1 RHCE RHD | 4.49e-05 | 1017 | 53 | 11 | GO:0098660 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 5.95e-05 | 162 | 53 | 5 | GO:0015748 | |
| GeneOntologyBiologicalProcess | superoxide metabolic process | 6.14e-05 | 83 | 53 | 4 | GO:0006801 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.38e-05 | 87 | 53 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 8.38e-05 | 559 | 53 | 8 | GO:0042391 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 9.58e-05 | 93 | 53 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | ammonium homeostasis | 9.65e-05 | 6 | 53 | 2 | GO:0097272 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 9.85e-05 | 291 | 53 | 6 | GO:0072593 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | NALCN P2RX7 SCN1A SCN3A SCN8A SCN9A TMEM63B KCNQ2 ATP1B2 ADCYAP1R1 | 1.23e-04 | 942 | 53 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | aminophospholipid translocation | 1.35e-04 | 7 | 53 | 2 | GO:0140331 | |
| GeneOntologyBiologicalProcess | heart process | 1.37e-04 | 309 | 53 | 6 | GO:0003015 | |
| GeneOntologyBiologicalProcess | nerve development | 1.77e-04 | 109 | 53 | 4 | GO:0021675 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 1.80e-04 | 8 | 53 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | aminophospholipid transport | 2.31e-04 | 9 | 53 | 2 | GO:0015917 | |
| GeneOntologyBiologicalProcess | lipid transport | 2.98e-04 | 506 | 53 | 7 | GO:0006869 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.18e-04 | 127 | 53 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | sensory perception | OR52A4P P2RX7 SCN1A SCN8A SCN9A TMEM63B KCNQ2 ATP8B1 OPN1SW VN1R1 | 3.49e-04 | 1072 | 53 | 10 | GO:0007600 |
| GeneOntologyBiologicalProcess | erythrocyte development | 3.82e-04 | 55 | 53 | 3 | GO:0048821 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 4.96e-04 | 13 | 53 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | circulatory system process | 5.27e-04 | 733 | 53 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | lipid localization | 5.77e-04 | 565 | 53 | 7 | GO:0010876 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine acyl-chain remodeling | 5.78e-04 | 14 | 53 | 2 | GO:0036151 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | NALCN P2RX7 SCN1A SCN3A SCN8A SCN9A TMEM63B KCNQ2 ATP1B2 ADCYAP1R1 | 6.36e-04 | 1157 | 53 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 6.43e-04 | 153 | 53 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide metabolic process | 6.83e-04 | 67 | 53 | 3 | GO:0042743 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 8.78e-04 | 73 | 53 | 3 | GO:0071715 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 8.91e-04 | 167 | 53 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | metal ion transport | 9.23e-04 | 1000 | 53 | 9 | GO:0030001 | |
| GeneOntologyBiologicalProcess | heart contraction | 9.91e-04 | 298 | 53 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.02e-03 | 173 | 53 | 4 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.06e-03 | 175 | 53 | 4 | GO:0009582 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport into cytosol | 1.32e-03 | 21 | 53 | 2 | GO:0010524 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 1.38e-03 | 188 | 53 | 4 | GO:0007009 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 1.45e-03 | 22 | 53 | 2 | GO:0050665 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 1.61e-03 | 90 | 53 | 3 | GO:0140962 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 1.67e-03 | 198 | 53 | 4 | GO:0007605 | |
| GeneOntologyBiologicalProcess | positive regulation of icosanoid secretion | 1.72e-03 | 24 | 53 | 2 | GO:0032305 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.95e-08 | 17 | 55 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 1.28e-07 | 18 | 55 | 4 | GO:0043020 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.70e-07 | 29 | 55 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | transporter complex | CYBB NALCN SCN1A SCN3A SCN8A SCN9A KCNQ2 ATP11C ATP8B1 ATP1B2 | 1.48e-06 | 550 | 55 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | node of Ranvier | 1.90e-05 | 20 | 55 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.33e-05 | 785 | 55 | 10 | GO:0098797 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.75e-05 | 378 | 55 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | axon initial segment | 6.00e-05 | 29 | 55 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 6.30e-05 | 523 | 55 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | membrane protein complex | CYBB NOX1 NALCN SCN1A SCN3A SCN8A SCN9A KCNQ2 NOX4 NOX3 ATP1B2 RHCE RHD | 1.06e-04 | 1498 | 55 | 13 | GO:0098796 |
| GeneOntologyCellularComponent | ankyrin-1 complex | 3.02e-04 | 10 | 55 | 2 | GO:0170014 | |
| GeneOntologyCellularComponent | cation channel complex | 3.79e-04 | 235 | 55 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYBB TRAM1L1 MBOAT7 TRAM1 SPPL3 UGT2B15 NOX4 ALG8 ATP11C MBOAT2 LMBRD1 | 4.67e-04 | 1293 | 55 | 11 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYBB TRAM1L1 MBOAT7 TRAM1 SPPL3 UGT2B15 NOX4 ALG8 ATP11C MBOAT2 LMBRD1 | 4.86e-04 | 1299 | 55 | 11 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CYBB TRAM1L1 MBOAT7 TRAM1 SPPL3 UGT2B15 NOX4 ALG8 ATP11C MBOAT2 LMBRD1 | 5.82e-04 | 1327 | 55 | 11 | GO:0042175 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 6.06e-04 | 14 | 55 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | oxidoreductase complex | 8.52e-04 | 161 | 55 | 4 | GO:1990204 | |
| GeneOntologyCellularComponent | main axon | 1.67e-03 | 89 | 55 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 2.64e-03 | 29 | 55 | 2 | GO:0097038 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.83e-03 | 35 | 55 | 2 | GO:0098553 | |
| HumanPheno | Focal hemiclonic seizure | 2.07e-06 | 25 | 20 | 4 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 2.86e-06 | 27 | 20 | 4 | HP:0011171 | |
| HumanPheno | Generalized clonic seizure | 7.43e-06 | 34 | 20 | 4 | HP:0011169 | |
| HumanPheno | Focal automatism seizure | 1.11e-05 | 12 | 20 | 3 | HP:0032898 | |
| HumanPheno | Clonic seizure | 1.15e-05 | 81 | 20 | 5 | HP:0020221 | |
| HumanPheno | Infection-related seizure | 1.34e-05 | 145 | 20 | 6 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.34e-05 | 145 | 20 | 6 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.34e-05 | 145 | 20 | 6 | HP:0002373 | |
| HumanPheno | Dermatological manifestations of systemic disorders | 1.59e-05 | 435 | 20 | 9 | HP:0001005 | |
| HumanPheno | Focal clonic seizure | 1.76e-05 | 42 | 20 | 4 | HP:0002266 | |
| HumanPheno | Facial tics | 2.29e-05 | 15 | 20 | 3 | HP:0011468 | |
| HumanPheno | Complex febrile seizure | 2.81e-05 | 16 | 20 | 3 | HP:0011172 | |
| HumanPheno | Anti-erythrocyte autoantibody positivity | 4.38e-05 | 3 | 20 | 2 | HP:6000388 | |
| HumanPheno | Positive direct antiglobulin test | 4.38e-05 | 3 | 20 | 2 | HP:0032366 | |
| HumanPheno | Generalized tonic seizure | 9.44e-05 | 64 | 20 | 4 | HP:0010818 | |
| HumanPheno | Focal impaired awareness seizure | 9.84e-05 | 126 | 20 | 5 | HP:0002384 | |
| HumanPheno | Multifocal epileptiform discharges | 1.07e-04 | 66 | 20 | 4 | HP:0010841 | |
| HumanPheno | Epileptic aura | 1.13e-04 | 25 | 20 | 3 | HP:0033348 | |
| HumanPheno | Focal head nodding automatism seizure | 1.45e-04 | 5 | 20 | 2 | HP:0032906 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 1.45e-04 | 5 | 20 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 1.45e-04 | 5 | 20 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 1.45e-04 | 5 | 20 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 1.45e-04 | 5 | 20 | 2 | HP:0032823 | |
| HumanPheno | Generalized myoclonic seizure | 2.11e-04 | 148 | 20 | 5 | HP:0002123 | |
| HumanPheno | Normal interictal EEG | 2.18e-04 | 6 | 20 | 2 | HP:0002372 | |
| HumanPheno | Calcaneovalgus deformity | 2.87e-04 | 34 | 20 | 3 | HP:0001848 | |
| HumanPheno | Eyelid myoclonia seizure | 3.04e-04 | 7 | 20 | 2 | HP:0032678 | |
| HumanPheno | Abnormality of taste sensation | 3.04e-04 | 7 | 20 | 2 | HP:0000223 | |
| HumanPheno | Deformed tarsal bones | 3.13e-04 | 35 | 20 | 3 | HP:0008119 | |
| HumanPheno | Disturbance of facial expression | 3.40e-04 | 36 | 20 | 3 | HP:0005324 | |
| HumanPheno | Spherocytosis | 4.04e-04 | 8 | 20 | 2 | HP:0004444 | |
| HumanPheno | Photosensitive myoclonic seizure | 4.04e-04 | 8 | 20 | 2 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 4.04e-04 | 8 | 20 | 2 | HP:0200048 | |
| HumanPheno | Focal non-motor seizure | 4.66e-04 | 40 | 20 | 3 | HP:0032679 | |
| HumanPheno | Sudden unexpected death in epilepsy | 6.47e-04 | 10 | 20 | 2 | HP:0033258 | |
| HumanPheno | Focal autonomic seizure | 7.89e-04 | 11 | 20 | 2 | HP:0011154 | |
| HumanPheno | Limited neck range of motion | 7.89e-04 | 11 | 20 | 2 | HP:0000466 | |
| HumanPheno | Neonatal seizure | 7.89e-04 | 11 | 20 | 2 | HP:0032807 | |
| HumanPheno | Abnormal fetal physiology | 8.75e-04 | 308 | 20 | 6 | HP:0034059 | |
| HumanPheno | Epilepsia partialis continua | 9.44e-04 | 12 | 20 | 2 | HP:0012847 | |
| HumanPheno | Hypochromia | 9.44e-04 | 12 | 20 | 2 | HP:0032231 | |
| HumanPheno | Cyanosis | 9.64e-04 | 117 | 20 | 4 | HP:0000961 | |
| HumanPheno | Status epilepticus | 9.93e-04 | 207 | 20 | 5 | HP:0002133 | |
| HumanPheno | EEG with focal epileptiform discharges | 9.95e-04 | 118 | 20 | 4 | HP:0011185 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 1.01e-03 | 52 | 20 | 3 | HP:0007334 | |
| HumanPheno | Epileptic encephalopathy | 1.03e-03 | 119 | 20 | 4 | HP:0200134 | |
| HumanPheno | Increased red cell osmotic fragility | 1.11e-03 | 13 | 20 | 2 | HP:0005502 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 1.11e-03 | 13 | 20 | 2 | HP:0007058 | |
| HumanPheno | Stomatocytosis | 1.30e-03 | 14 | 20 | 2 | HP:0004446 | |
| HumanPheno | Abnormality of the calcaneus | 1.32e-03 | 57 | 20 | 3 | HP:0008364 | |
| HumanPheno | Focal motor seizure | 1.47e-03 | 131 | 20 | 4 | HP:0011153 | |
| HumanPheno | Aortopulmonary collateral arteries | 1.49e-03 | 15 | 20 | 2 | HP:0031834 | |
| HumanPheno | Abnormal erythrocyte physiology | 1.49e-03 | 15 | 20 | 2 | HP:0020054 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.49e-03 | 15 | 20 | 2 | HP:0007207 | |
| HumanPheno | Reduced haptoglobin level | 1.49e-03 | 15 | 20 | 2 | HP:0020181 | |
| HumanPheno | Generalized-onset motor seizure | 1.53e-03 | 228 | 20 | 5 | HP:0032677 | |
| HumanPheno | Ascites | 1.60e-03 | 134 | 20 | 4 | HP:0001541 | |
| HumanPheno | Focal-onset seizure | 1.61e-03 | 346 | 20 | 6 | HP:0007359 | |
| HumanPheno | Dysgenesis of the hippocampus | 1.70e-03 | 16 | 20 | 2 | HP:0025101 | |
| HumanPheno | Abnormal circulating haptoglobin concentration | 1.70e-03 | 16 | 20 | 2 | HP:0020179 | |
| HumanPheno | Tonic seizure | 1.88e-03 | 140 | 20 | 4 | HP:0032792 | |
| HumanPheno | Atypical absence status epilepticus | 1.92e-03 | 17 | 20 | 2 | HP:0011151 | |
| HumanPheno | Focal motor status epilepticus | 1.92e-03 | 17 | 20 | 2 | HP:0032663 | |
| HumanPheno | Focal emotional seizure with laughing | 1.92e-03 | 17 | 20 | 2 | HP:0010821 | |
| HumanPheno | Prenatal movement abnormality | 2.15e-03 | 246 | 20 | 5 | HP:0001557 | |
| HumanPheno | Visually-induced seizure | 2.16e-03 | 18 | 20 | 2 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.16e-03 | 18 | 20 | 2 | HP:0032860 | |
| HumanPheno | Focal emotional seizure | 2.16e-03 | 18 | 20 | 2 | HP:0025613 | |
| HumanPheno | Abnormality of the amniotic fluid | 2.19e-03 | 504 | 20 | 7 | HP:0001560 | |
| HumanPheno | Dialeptic seizure | 2.35e-03 | 251 | 20 | 5 | HP:0011146 | |
| HumanPheno | Impulsivity | 2.36e-03 | 149 | 20 | 4 | HP:0100710 | |
| Domain | Cyt_b245_heavy_chain | 7.25e-11 | 4 | 56 | 4 | IPR000778 | |
| Domain | Na_trans_cytopl | 1.08e-09 | 6 | 56 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 1.08e-09 | 6 | 56 | 4 | IPR024583 | |
| Domain | NAD_binding_6 | 2.52e-09 | 7 | 56 | 4 | PF08030 | |
| Domain | FAD-bd_8 | 2.52e-09 | 7 | 56 | 4 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 2.52e-09 | 7 | 56 | 4 | IPR013121 | |
| Domain | FAD_binding_8 | 2.52e-09 | 7 | 56 | 4 | PF08022 | |
| Domain | Na_channel_asu | 1.50e-08 | 10 | 56 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 1.50e-08 | 10 | 56 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 1.50e-08 | 10 | 56 | 4 | PF06512 | |
| Domain | Fe3_Rdtase_TM_dom | 3.52e-08 | 12 | 56 | 4 | IPR013130 | |
| Domain | Ferric_reduct | 3.52e-08 | 12 | 56 | 4 | PF01794 | |
| Domain | Fd_Rdtase_FAD-bd | 2.72e-07 | 19 | 56 | 4 | IPR017927 | |
| Domain | FAD_FR | 2.72e-07 | 19 | 56 | 4 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 2.72e-07 | 19 | 56 | 4 | IPR017938 | |
| Domain | Channel_four-helix_dom | 7.51e-07 | 57 | 56 | 5 | IPR027359 | |
| Domain | - | 7.51e-07 | 57 | 56 | 5 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.15e-06 | 114 | 56 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.15e-06 | 114 | 56 | 6 | PF00520 | |
| Domain | TLC | 1.39e-05 | 16 | 56 | 3 | PS50922 | |
| Domain | TRAM_LAG1_CLN8 | 1.39e-05 | 16 | 56 | 3 | PF03798 | |
| Domain | TLC-dom | 1.39e-05 | 16 | 56 | 3 | IPR006634 | |
| Domain | TLC | 1.39e-05 | 16 | 56 | 3 | SM00724 | |
| Domain | Translocation_assoc_membrane | 2.64e-05 | 3 | 56 | 2 | IPR016447 | |
| Domain | TRAM1 | 2.64e-05 | 3 | 56 | 2 | PF08390 | |
| Domain | TRAM1 | 2.64e-05 | 3 | 56 | 2 | IPR013599 | |
| Domain | IQ | 6.07e-05 | 71 | 56 | 4 | PF00612 | |
| Domain | Ammonium_transpt | 8.78e-05 | 5 | 56 | 2 | IPR001905 | |
| Domain | Ammonium_transp | 8.78e-05 | 5 | 56 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 8.78e-05 | 5 | 56 | 2 | IPR024041 | |
| Domain | RhesusRHD | 8.78e-05 | 5 | 56 | 2 | IPR002229 | |
| Domain | IQ | 1.02e-04 | 81 | 56 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.53e-04 | 90 | 56 | 4 | IPR000048 | |
| Domain | IQ | 1.74e-04 | 93 | 56 | 4 | PS50096 | |
| Domain | - | 1.84e-04 | 7 | 56 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 1.84e-04 | 7 | 56 | 2 | IPR029020 | |
| Domain | MBOAT_fam | 4.77e-04 | 11 | 56 | 2 | IPR004299 | |
| Domain | AdipoR/HlyIII-related | 4.77e-04 | 11 | 56 | 2 | IPR004254 | |
| Domain | MBOAT | 4.77e-04 | 11 | 56 | 2 | PF03062 | |
| Domain | HlyIII | 4.77e-04 | 11 | 56 | 2 | PF03006 | |
| Domain | P_typ_ATPase_c | 7.85e-04 | 14 | 56 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 7.85e-04 | 14 | 56 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 7.85e-04 | 14 | 56 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 7.85e-04 | 14 | 56 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 7.85e-04 | 14 | 56 | 2 | PF16209 | |
| Domain | EF-hand-dom_pair | 1.67e-03 | 287 | 56 | 5 | IPR011992 | |
| Domain | - | 4.13e-03 | 32 | 56 | 2 | 2.70.150.10 | |
| Domain | - | 4.13e-03 | 32 | 56 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 4.93e-03 | 35 | 56 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.21e-03 | 36 | 56 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 5.21e-03 | 36 | 56 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.21e-03 | 36 | 56 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.50e-03 | 37 | 56 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.50e-03 | 37 | 56 | 2 | PF00122 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 6.40e-03 | 40 | 56 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 6.40e-03 | 40 | 56 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 6.40e-03 | 40 | 56 | 2 | IPR001879 | |
| Domain | ABC_transporter_CS | 7.04e-03 | 42 | 56 | 2 | IPR017871 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.60e-08 | 31 | 41 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.09e-06 | 32 | 41 | 4 | M27455 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 2.37e-06 | 33 | 41 | 4 | M39645 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 8.81e-06 | 367 | 41 | 8 | M48346 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.51e-05 | 121 | 41 | 5 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.55e-05 | 130 | 41 | 5 | M27454 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 4.43e-05 | 24 | 41 | 3 | M27553 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 5.02e-05 | 25 | 41 | 3 | MM15269 | |
| Pathway | WP_DRAVET_SYNDROME | 7.11e-05 | 28 | 41 | 3 | M45519 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 1.72e-04 | 7 | 41 | 2 | MM15703 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 2.29e-04 | 8 | 41 | 2 | M45025 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.90e-04 | 203 | 41 | 5 | M5485 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 5.39e-04 | 55 | 41 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 5.99e-04 | 57 | 41 | 3 | MM15643 | |
| Pathway | WP_FERROPTOSIS | 8.41e-04 | 64 | 41 | 3 | M39768 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 8.46e-04 | 15 | 41 | 2 | MM14762 | |
| Pathway | WP_GPCRS_ODORANT | 1.09e-03 | 157 | 41 | 4 | MM15872 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | 1.09e-03 | 17 | 41 | 2 | MM14580 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | 1.09e-03 | 17 | 41 | 2 | M626 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.66e-03 | 176 | 41 | 4 | MM15718 | |
| Pathway | REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS | 1.67e-03 | 21 | 41 | 2 | M27917 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 1.84e-03 | 22 | 41 | 2 | M27084 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.91e-03 | 183 | 41 | 4 | M997 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.47e-03 | 93 | 41 | 3 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.55e-03 | 94 | 41 | 3 | M41818 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | 2.77e-03 | 27 | 41 | 2 | M643 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | 2.97e-03 | 28 | 41 | 2 | MM14578 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | 2.97e-03 | 28 | 41 | 2 | MM14575 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.19e-03 | 29 | 41 | 2 | M45015 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | 3.19e-03 | 29 | 41 | 2 | M702 | |
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 22277655 | ||
| Pubmed | Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction. | 3.01e-11 | 5 | 56 | 4 | 24608713 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 9.02e-11 | 6 | 56 | 4 | 23652591 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 16775014 | ||
| Pubmed | Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. | 2.10e-10 | 7 | 56 | 4 | 19005069 | |
| Pubmed | 7.55e-10 | 9 | 56 | 4 | 16382098 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 22933115 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 19843513 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 36709665 | ||
| Pubmed | The NADPH Oxidase Nox2 Mediates Vitamin D-Induced Vascular Regeneration in Male Mice. | 3.95e-09 | 3 | 56 | 3 | 27399878 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 33895391 | ||
| Pubmed | Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses. | 3.95e-09 | 3 | 56 | 3 | 31308397 | |
| Pubmed | Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors. | 3.95e-09 | 3 | 56 | 3 | 33836590 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 20877715 | ||
| Pubmed | Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. | 3.95e-09 | 3 | 56 | 3 | 22456182 | |
| Pubmed | A constitutive NADPH oxidase-like system containing gp91phox homologs in human keratinocytes. | 3.95e-09 | 3 | 56 | 3 | 15102091 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 33267663 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 10974555 | ||
| Pubmed | Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy. | 3.95e-09 | 3 | 56 | 3 | 19471020 | |
| Pubmed | 4.26e-09 | 13 | 56 | 4 | 15123669 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 17537961 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 35031483 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 29578003 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 21156207 | ||
| Pubmed | Models for discovery of targeted therapy in genetic epileptic encephalopathies. | 1.58e-08 | 4 | 56 | 3 | 28742937 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 31919083 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 9882350 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 3.94e-08 | 5 | 56 | 3 | 22875929 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 15256399 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 25116588 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 21901141 | ||
| Pubmed | Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. | 3.94e-08 | 5 | 56 | 3 | 22337127 | |
| Pubmed | NOX isoforms in the development of abdominal aortic aneurysm. | 7.88e-08 | 6 | 56 | 3 | 27912196 | |
| Pubmed | The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye. | 7.88e-08 | 6 | 56 | 3 | 32483169 | |
| Pubmed | APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. | 7.88e-08 | 6 | 56 | 3 | 28165467 | |
| Pubmed | Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury. | 7.88e-08 | 6 | 56 | 3 | 24051369 | |
| Pubmed | Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia. | 7.88e-08 | 6 | 56 | 3 | 19941336 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.01e-07 | 139 | 56 | 6 | 16985003 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.38e-07 | 7 | 56 | 3 | 25818041 | |
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 15509740 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 15746173 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 21212270 | ||
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 30755476 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 8.61e-07 | 12 | 56 | 3 | 30175250 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8188244 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22038300 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 20457132 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.55e-06 | 2 | 56 | 2 | 37901435 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11724987 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 20715105 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23064009 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25066694 | ||
| Pubmed | DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. | 2.55e-06 | 2 | 56 | 2 | 17900276 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32697929 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.55e-06 | 2 | 56 | 2 | 26410685 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 10627438 | ||
| Pubmed | NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. | 2.55e-06 | 2 | 56 | 2 | 23100220 | |
| Pubmed | NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice. | 2.55e-06 | 2 | 56 | 2 | 24379900 | |
| Pubmed | Expression and localization of NOX2 and NOX4 in primary human endothelial cells. | 2.55e-06 | 2 | 56 | 2 | 15706079 | |
| Pubmed | Polymorphisms in the promoter regions of RHD and RHCE genes in the Chinese Han population. | 2.55e-06 | 2 | 56 | 2 | 37823181 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 30089826 | ||
| Pubmed | ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. | 2.55e-06 | 2 | 56 | 2 | 23216904 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26222337 | ||
| Pubmed | Isoforms and functions of NAD(P)H oxidase at the macula densa. | 2.55e-06 | 2 | 56 | 2 | 19204183 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 20952384 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 14551238 | ||
| Pubmed | Review: the molecular basis of the Rh blood group phenotypes. | 2.55e-06 | 2 | 56 | 2 | 15373666 | |
| Pubmed | Activation of NADPH oxidases leads to DNA damage in esophageal cells. | 2.55e-06 | 2 | 56 | 2 | 28855537 | |
| Pubmed | Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization. | 2.55e-06 | 2 | 56 | 2 | 19995913 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16877542 | ||
| Pubmed | Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations. | 2.55e-06 | 2 | 56 | 2 | 26579938 | |
| Pubmed | NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. | 2.55e-06 | 2 | 56 | 2 | 19661248 | |
| Pubmed | Redox modifier genes in amyotrophic lateral sclerosis in mice. | 2.55e-06 | 2 | 56 | 2 | 17853944 | |
| Pubmed | Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. | 2.55e-06 | 2 | 56 | 2 | 22920224 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 34968422 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 33301718 | ||
| Pubmed | Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia. | 2.55e-06 | 2 | 56 | 2 | 29193104 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1898705 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 27212019 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11161244 | ||
| Pubmed | NADPH oxidase 4 mediates flow-induced superoxide production in thick ascending limbs. | 2.55e-06 | 2 | 56 | 2 | 22896039 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18783311 | ||
| Pubmed | RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). | 2.55e-06 | 2 | 56 | 2 | 25857637 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 30125808 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22738288 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 2.55e-06 | 2 | 56 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 2.55e-06 | 2 | 56 | 2 | 25172946 | |
| Pubmed | Multiple Rh messenger RNA isoforms are produced by alternative splicing. | 2.55e-06 | 2 | 56 | 2 | 1379850 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32276107 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15883163 | ||
| Pubmed | Endothelial NADPH oxidases: which NOX to target in vascular disease? | 2.55e-06 | 2 | 56 | 2 | 25066192 | |
| Pubmed | Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases. | 2.55e-06 | 2 | 56 | 2 | 22412195 | |
| Pubmed | RHCE variants inherited with altered RHD alleles in Brazilian blood donors. | 2.55e-06 | 2 | 56 | 2 | 27111588 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 10329015 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8822955 | ||
| Pubmed | P2X7 receptor activation induces inflammatory responses in salivary gland epithelium. | 2.55e-06 | 2 | 56 | 2 | 22875784 | |
| Pubmed | Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4. | 2.55e-06 | 2 | 56 | 2 | 22875785 | |
| Pubmed | Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis. | 2.55e-06 | 2 | 56 | 2 | 26988594 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25079350 | ||
| Interaction | SCN11A interactions | 5.69e-08 | 15 | 53 | 4 | int:SCN11A | |
| Interaction | CACNA1B interactions | 2.64e-06 | 37 | 53 | 4 | int:CACNA1B | |
| Interaction | NALCN interactions | 6.12e-06 | 14 | 53 | 3 | int:NALCN | |
| Interaction | SCN5A interactions | 6.99e-06 | 47 | 53 | 4 | int:SCN5A | |
| Interaction | SCN9A interactions | 2.21e-05 | 21 | 53 | 3 | int:SCN9A | |
| Interaction | YIPF4 interactions | 3.06e-05 | 68 | 53 | 4 | int:YIPF4 | |
| Interaction | CACNA1D interactions | 3.34e-05 | 24 | 53 | 3 | int:CACNA1D | |
| Interaction | UPK1A interactions | 4.60e-05 | 150 | 53 | 5 | int:UPK1A | |
| Interaction | SCN1A interactions | 5.98e-05 | 29 | 53 | 3 | int:SCN1A | |
| Interaction | GPR21 interactions | 6.10e-05 | 81 | 53 | 4 | int:GPR21 | |
| Interaction | CRELD1 interactions | 6.83e-05 | 163 | 53 | 5 | int:CRELD1 | |
| Interaction | GPR52 interactions | 1.06e-04 | 35 | 53 | 3 | int:GPR52 | |
| Interaction | TPRA1 interactions | 1.15e-04 | 36 | 53 | 3 | int:TPRA1 | |
| Interaction | YIPF3 interactions | 1.27e-04 | 186 | 53 | 5 | int:YIPF3 | |
| Interaction | ADCYAP1R1 interactions | 1.41e-04 | 7 | 53 | 2 | int:ADCYAP1R1 | |
| Interaction | SLC22A4 interactions | 1.48e-04 | 192 | 53 | 5 | int:SLC22A4 | |
| Interaction | SCN4B interactions | 1.88e-04 | 8 | 53 | 2 | int:SCN4B | |
| Interaction | TMEM120B interactions | 2.22e-04 | 113 | 53 | 4 | int:TMEM120B | |
| Interaction | LMBRD1 interactions | 2.41e-04 | 9 | 53 | 2 | int:LMBRD1 | |
| Interaction | SCN3B interactions | 2.44e-04 | 214 | 53 | 5 | int:SCN3B | |
| Interaction | SLC22A9 interactions | 2.79e-04 | 120 | 53 | 4 | int:SLC22A9 | |
| Interaction | NKG7 interactions | 3.27e-04 | 51 | 53 | 3 | int:NKG7 | |
| Interaction | KDELR3 interactions | 3.27e-04 | 51 | 53 | 3 | int:KDELR3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.83e-05 | 127 | 56 | 4 | chr2q24 | |
| Cytoband | 2q24 | 7.98e-05 | 11 | 56 | 2 | 2q24 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.57e-09 | 9 | 40 | 4 | 1203 | |
| GeneFamily | TLC domain containing | 1.19e-06 | 10 | 40 | 3 | 1374 | |
| GeneFamily | Membrane bound O-acyltransferases | 9.95e-05 | 7 | 40 | 2 | 1036 | |
| GeneFamily | Progestin and adipoQ receptor family | 2.59e-04 | 11 | 40 | 2 | 930 | |
| GeneFamily | ATPase phospholipid transporting | 4.92e-04 | 15 | 40 | 2 | 1210 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.03e-03 | 37 | 40 | 2 | 454 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.29e-02 | 78 | 40 | 2 | 262 | |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.23e-06 | 422 | 53 | 8 | PP_RBC_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#5_top-relative-expression-ranked_500 | 1.87e-05 | 131 | 53 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k5 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 7.22e-05 | 89 | 53 | 4 | GSM791108_100 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_500 | 1.03e-04 | 438 | 53 | 7 | gudmap_kidney_adult_RenCorpuscGlomer_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#3_top-relative-expression-ranked_500 | 1.09e-04 | 99 | 53 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 1.36e-04 | 40 | 53 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.47e-04 | 202 | 53 | 5 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.80e-04 | 211 | 53 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_500_k-means-cluster#2 | 2.01e-04 | 216 | 53 | 5 | PP_RBC_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.44e-04 | 122 | 53 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k3 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 3.74e-09 | 187 | 56 | 7 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.89e-08 | 168 | 56 | 6 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.89e-08 | 168 | 56 | 6 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | Healthy-RBC|Healthy / disease group, cell group and cell class | 9.39e-08 | 177 | 56 | 6 | 945d72ab52efa9a9468daace9f9ec676a891d963 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 186 | 56 | 6 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 186 | 56 | 6 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-07 | 187 | 56 | 6 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | severe_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 1.52e-07 | 192 | 56 | 6 | 1b4e28fd2e3d70ab48dbe96b280d35395889fbe2 | |
| ToppCell | Healthy-RBC|World / disease group, cell group and cell class | 2.89e-06 | 177 | 56 | 5 | 2ce41e37fa7139c7bd2b464bd86c5601dc501515 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.05e-06 | 179 | 56 | 5 | dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.05e-06 | 179 | 56 | 5 | 64672528f73ac0921f9c7df72e14ecbfac4d5270 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.05e-06 | 179 | 56 | 5 | fa0dd87111d399649cdea55f2e610ebc169e8a56 | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 3.22e-06 | 181 | 56 | 5 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-06 | 183 | 56 | 5 | b52d7683dc6652766e814ebe935c264ecd610c4b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-06 | 183 | 56 | 5 | 1d77d8d8c8f78f43dd8864e76f294ee66d4942c2 | |
| ToppCell | COVID-19_Severe-RBC|COVID-19_Severe / disease group, cell group and cell class | 3.49e-06 | 184 | 56 | 5 | bb58244194ffb5558fbe85c5f856888210dcb1e8 | |
| ToppCell | COVID-19_Severe-RBC|World / disease group, cell group and cell class | 3.59e-06 | 185 | 56 | 5 | 96b7058b1b282134970aa9e75285760a9f94a8b5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.68e-06 | 186 | 56 | 5 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 186 | 56 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-06 | 187 | 56 | 5 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 3.88e-06 | 188 | 56 | 5 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.98e-06 | 189 | 56 | 5 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.09e-06 | 190 | 56 | 5 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | severe_COVID-19-RBC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.09e-06 | 190 | 56 | 5 | 3a5723c2daf58c1932edd70910db4b8b30f63f42 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 192 | 56 | 5 | a94f47a664a3c9d1b0250269674453309ab4bf95 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 4.52e-06 | 194 | 56 | 5 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | 15-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | 511bfc06c34d5add2ae561cca463d1e4e2d43e20 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.75e-06 | 196 | 56 | 5 | c391d6359634145455c71c7f051bf34ff0eb666d | |
| ToppCell | 15-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | bf2670e5ae996a19987bc70aa5a37d133db789eb | |
| ToppCell | erythropoietic-Erythrocyte|World / Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | 1642d9340f621cd55987ef8154b48aa306f0f0c8 | |
| ToppCell | 21-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 4.87e-06 | 197 | 56 | 5 | 9f8eb6305ade0654bbcd8f19963be0b64af083de | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 4.87e-06 | 197 | 56 | 5 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | 21-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 4.87e-06 | 197 | 56 | 5 | 4710b55806a618076a954190f519e49c55d300d3 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 5.25e-06 | 200 | 56 | 5 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 126 | 56 | 4 | 65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3 | |
| ToppCell | Bronchial-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 126 | 56 | 4 | b6482ef18e6d9e12ba4810ce7845f9f991cb95bc | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 126 | 56 | 4 | 12f3d0f60db462f2a9799b3a06005bc871670760 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 137 | 56 | 4 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 137 | 56 | 4 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 160 | 56 | 4 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 160 | 56 | 4 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-05 | 169 | 56 | 4 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 175 | 56 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 175 | 56 | 4 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.09e-05 | 176 | 56 | 4 | 9af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 179 | 56 | 4 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | Multiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 7.57e-05 | 179 | 56 | 4 | 15763dc59ee6186416e203ffbb450ae4608eba59 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-05 | 181 | 56 | 4 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | HSPCs-Erythroblasts|HSPCs / Lineage and Cell class | 7.90e-05 | 181 | 56 | 4 | 4ded490f190af7ace343acdf317edc7373484d08 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.25e-05 | 183 | 56 | 4 | 1db466cf757813322db1cdcc0bf1d91c062fd9de | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_reticulocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.25e-05 | 183 | 56 | 4 | 5470e5ac3439cfc96acd2202f6b1e386779a6637 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 185 | 56 | 4 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.60e-05 | 185 | 56 | 4 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.60e-05 | 185 | 56 | 4 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 8.60e-05 | 185 | 56 | 4 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | a45756f91b62cf0fac3582786e5868deb8fd8435 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 185 | 56 | 4 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.60e-05 | 185 | 56 | 4 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 8.60e-05 | 185 | 56 | 4 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.60e-05 | 185 | 56 | 4 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 185 | 56 | 4 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 8.60e-05 | 185 | 56 | 4 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 8.60e-05 | 185 | 56 | 4 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.96e-05 | 187 | 56 | 4 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue | 8.96e-05 | 187 | 56 | 4 | 61d346c9873c2edb3ce224a0c063c54d9a68309e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 187 | 56 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.15e-05 | 188 | 56 | 4 | f81099b5b3f1f85a28445bc663efcf73baccb2be | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 188 | 56 | 4 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.15e-05 | 188 | 56 | 4 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.15e-05 | 188 | 56 | 4 | 05b3ade422beeb3db73d350fe192c21bfcfef188 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 9.34e-05 | 189 | 56 | 4 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 9.34e-05 | 189 | 56 | 4 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-05 | 190 | 56 | 4 | a273fc119baebc11020009c923beafeebb6428c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-05 | 190 | 56 | 4 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.53e-05 | 190 | 56 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 9.53e-05 | 190 | 56 | 4 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 191 | 56 | 4 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.92e-05 | 192 | 56 | 4 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 9.92e-05 | 192 | 56 | 4 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 193 | 56 | 4 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | Megakaryocytic-erythropoietic|World / Lineage, cell class and subclass | 1.01e-04 | 193 | 56 | 4 | 805c2e2e5d8a9df5ce796d5c0206d6493ab53c88 | |
| ToppCell | severe_influenza-RBC|severe_influenza / disease group, cell group and cell class (v2) | 1.01e-04 | 193 | 56 | 4 | ffb0b3c2cce13b6891157f0fede2600f3938670e | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.03e-04 | 194 | 56 | 4 | f0ababe8daa57f6827a3e2e72c884d9e8b2687a3 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-04 | 195 | 56 | 4 | 4759018a7c016cb2e3df5696f1e5f912c7c9ee17 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-04 | 195 | 56 | 4 | b24f6fe71fbcffe7ff1fd1374455c378837d6313 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 196 | 56 | 4 | 0aae78e73d53416d857bdf21f595a0a0a0ba7944 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 197 | 56 | 4 | d8f99a9f2367c8bc9308b0c64d0226875262927a | |
| ToppCell | erythropoietic|World / Lineage and Cell class | 1.10e-04 | 197 | 56 | 4 | a52546cebc222050c970e04cec97e4f48ab8fe10 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 197 | 56 | 4 | 97a837477043902f0f5c9db850a3bfa001ea74d1 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-04 | 198 | 56 | 4 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| Computational | Porins / transporters. | 2.65e-04 | 211 | 30 | 5 | MODULE_63 | |
| Drug | indoxacarb | 1.32e-07 | 49 | 56 | 5 | CID000107720 | |
| Drug | pheophytin | 4.49e-07 | 284 | 56 | 8 | CID000000250 | |
| Drug | 1, 3-diallylurea | 1.06e-06 | 74 | 56 | 5 | CID000074537 | |
| Drug | diphenyline | 1.67e-06 | 10 | 56 | 3 | CID000010292 | |
| Drug | Tetrodotoxin | 2.81e-06 | 40 | 56 | 4 | ctd:D013779 | |
| Drug | dihydroethidium | 3.67e-06 | 95 | 56 | 5 | CID000128682 | |
| Drug | Superoxides | 6.00e-06 | 105 | 56 | 5 | ctd:D013481 | |
| Drug | dalcetrapib | 6.28e-06 | 15 | 56 | 3 | ctd:C411602 | |
| Drug | Zonisamide | 9.35e-06 | 17 | 56 | 3 | DB00909 | |
| Drug | anacetrapib | 1.33e-05 | 19 | 56 | 3 | ctd:C530884 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.78e-05 | 3 | 56 | 2 | ctd:C561228 | |
| Drug | DCFH-DA | 6.00e-05 | 86 | 56 | 4 | CID000104913 | |
| Drug | Mequindox | 6.65e-05 | 32 | 56 | 3 | ctd:C545385 | |
| Drug | biphenylene | 7.99e-05 | 34 | 56 | 3 | CID000009214 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 8.05e-05 | 180 | 56 | 5 | 5203_UP | |
| Drug | CGP 42112A | 8.86e-05 | 6 | 56 | 2 | ctd:C060894 | |
| Drug | APETx1, Anthopleura elegantissima | 8.86e-05 | 6 | 56 | 2 | ctd:C475726 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.42e-09 | 10 | 56 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.42e-09 | 10 | 56 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.69e-09 | 12 | 56 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Anemia, Hemolytic, Congenital | 3.54e-06 | 2 | 56 | 2 | C0002881 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 3.54e-06 | 2 | 56 | 2 | C4551549 | |
| Disease | anxiety disorder (implicated_via_orthology) | 9.72e-06 | 22 | 56 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | B Virus Infection | 1.06e-05 | 3 | 56 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 1.06e-05 | 3 | 56 | 2 | C0032768 | |
| Disease | Rh Deficiency Syndrome | 1.06e-05 | 3 | 56 | 2 | C0272052 | |
| Disease | Herpesviridae Infections | 1.06e-05 | 3 | 56 | 2 | C0019372 | |
| Disease | Rh-Null, Regulator Type | 1.06e-05 | 3 | 56 | 2 | C1849387 | |
| Disease | epilepsy (implicated_via_orthology) | 1.47e-05 | 163 | 56 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | 1-oleoyl-GPI (18:1) measurement | 2.12e-05 | 4 | 56 | 2 | EFO_0800265 | |
| Disease | Familial benign neonatal epilepsy | 5.28e-05 | 6 | 56 | 2 | C0220669 | |
| Disease | Epilepsy | 5.58e-05 | 109 | 56 | 4 | C0014544 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 9.83e-05 | 8 | 56 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 9.83e-05 | 8 | 56 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0393703 | |
| Disease | Myoclonic Epilepsy | 1.26e-04 | 9 | 56 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.26e-04 | 9 | 56 | 2 | C3502809 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.58e-04 | 10 | 56 | 2 | C0917800 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 1.58e-04 | 10 | 56 | 2 | EFO_0800469 | |
| Disease | Myoclonic Astatic Epilepsy | 1.92e-04 | 11 | 56 | 2 | C0393702 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.72e-04 | 13 | 56 | 2 | C0751122 | |
| Disease | phosphatidate measurement | 3.66e-04 | 15 | 56 | 2 | EFO_0020047 | |
| Disease | Epilepsy, Cryptogenic | 5.16e-04 | 82 | 56 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 5.16e-04 | 82 | 56 | 3 | C0751111 | |
| Disease | Aura | 5.16e-04 | 82 | 56 | 3 | C0236018 | |
| Disease | ethylmalonate measurement | 6.58e-04 | 20 | 56 | 2 | EFO_0020009 | |
| Disease | Neurodevelopmental Disorders | 7.44e-04 | 93 | 56 | 3 | C1535926 | |
| Disease | obsolete_red blood cell distribution width | 9.15e-04 | 1347 | 56 | 9 | EFO_0005192 | |
| Disease | HDL cholesterol change measurement | 9.51e-04 | 24 | 56 | 2 | EFO_0007805 | |
| Disease | Myocardial Failure | 1.21e-03 | 110 | 56 | 3 | C1959583 | |
| Disease | Congestive heart failure | 1.21e-03 | 110 | 56 | 3 | C0018802 | |
| Disease | Heart failure | 1.21e-03 | 110 | 56 | 3 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.21e-03 | 110 | 56 | 3 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.21e-03 | 110 | 56 | 3 | C0235527 | |
| Disease | Heart Decompensation | 1.21e-03 | 110 | 56 | 3 | C1961112 | |
| Disease | HbA1c measurement | 1.72e-03 | 675 | 56 | 6 | EFO_0004541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLIHSFLYIYYVHWS | 106 | Q86UN6 | |
| HLIYYFIFLGFQLSW | 996 | Q8WWZ4 | |
| VTFFSHFFYLSLFFW | 476 | Q8IZF3 | |
| TCIYHFLVLSWYTFL | 6 | Q96IZ2 | |
| FFRSLHFFVEWFEYR | 166 | Q6IPU0 | |
| YKNFAFTLVHFWYSF | 956 | O43520 | |
| VTVYAFPFAHWLAFF | 306 | Q9GZQ6 | |
| FEVFWYTHHLFIFYI | 201 | Q9Y5S8 | |
| FLLCWLPYFSFHLYV | 296 | Q9BZJ8 | |
| YLALFCFGWYALHFL | 66 | Q6ZWT7 | |
| SWFRLSFVYNHYLFF | 541 | Q9NQZ7 | |
| YLFLHKFWFFSAAYY | 481 | Q9NUN5 | |
| SWAFILLFYLVFYGF | 36 | P14415 | |
| WAFIYHAYVFLLVFS | 91 | O43526 | |
| FYLLAFFFIFYSQIW | 256 | A6NMU1 | |
| DTLRYWASIYFCIHF | 421 | Q96N66 | |
| FFLKHYRYSWSFICT | 491 | Q5MIZ7 | |
| YGFVFTFLYWHLEDL | 461 | Q6ZSS7 | |
| NLLWYIPHYFYHFSF | 241 | Q86SM8 | |
| NYDIFWYTHNLFFVF | 186 | Q9NPH5 | |
| VFFHYCVVSNYFWLF | 231 | P41586 | |
| HFYRRYFWLVVAAFF | 276 | Q6ZVX9 | |
| WYHTLQILFFLVSAY | 246 | Q8TEZ7 | |
| YGTIKWFFHVIIFSY | 26 | Q99572 | |
| WFFHVIIFSYVCFAL | 31 | Q99572 | |
| FFLYWAVDATHAPVY | 226 | P34059 | |
| HFLFRFIVFFYLWGL | 6 | Q9Y680 | |
| LLFFLTFYHTELSWF | 431 | Q96SL1 | |
| LPTIVYYSAFFEAHW | 491 | Q5T3F8 | |
| ATFFVHFFYLSVFFW | 521 | Q8IZF7 | |
| YFEVFWYTHHLFVIF | 201 | P04839 | |
| FIFHSWILLFHFYFT | 61 | O96002 | |
| AFYHWQCIDVFVYFS | 151 | Q8NFI3 | |
| AFFITYEYVKWFLHA | 66 | Q70HW3 | |
| YHIAPVWAFYLQAAF | 26 | P03999 | |
| LWACFPFYFLYLSRH | 46 | P33527 | |
| FAFAYLAWLIYSIAF | 311 | Q9BXQ6 | |
| HYYFTVGWNIFDFVV | 1571 | Q15858 | |
| RHYYFTIGWNIFDFV | 1581 | Q9NY46 | |
| ELFWYTHHVFIVFFL | 201 | Q9HBY0 | |
| WLFYQDAEYLFHTFA | 816 | Q13018 | |
| RHYYFTIGWNIFDFV | 1596 | P35498 | |
| FAWFEYILSHVAKYF | 71 | Q9BVK2 | |
| HFVIWGSLAFYVFFS | 1026 | Q8NB49 | |
| KFFYISQLAYWFHAF | 166 | Q8N609 | |
| SQLAYWFHAFPELYF | 171 | Q8N609 | |
| HIYVFAAYFGLSVAW | 171 | Q02161 | |
| HFYVFAAYFGLTVAW | 171 | P18577 | |
| LLIYDVFWVFFSAYI | 196 | Q8TCT6 | |
| SFFVFYSVHSFLTIW | 281 | Q9GZP7 | |
| LLFYFVSYWFSAKVS | 21 | Q96MV1 | |
| LRHYYFTIGWNIFDF | 1576 | Q9UQD0 | |
| FANCSVYDFFVWLHY | 176 | P40126 | |
| YWHFLTDTFTAYYRL | 181 | Q68CL5 | |
| KFFYISQLAYWLHAF | 166 | Q15629 | |
| IHMLYFDFWFQIYDL | 216 | P54855 | |
| SLVLFYKAYHFWVFV | 196 | Q6UX68 | |
| KSYIALLHYWEFLFS | 2436 | O15050 | |
| IYLILYHAIFVFFTW | 56 | Q96MV8 | |
| WRSYFYFITLIFFLA | 296 | Q8IZF0 |